Types of Rectal Polyps
Rectal polyps are classified into two main categories: neoplastic polyps (which have malignant potential) and non-neoplastic polyps (which generally do not), with neoplastic polyps further subdivided into conventional adenomas and serrated lesions.
Neoplastic Polyps
Conventional Adenomas
These are the most common neoplastic polyps and include:
Tubular adenomas (TA): The most frequent type, accounting for the majority of adenomatous polyps. They remain relatively constant in frequency across all polyp sizes 1.
Tubulovillous adenomas (TVA): Mixed architecture polyps with both tubular and villous components. These carry higher malignant potential than pure tubular adenomas 2.
Villous adenomas: The least common but highest-risk conventional adenoma subtype, with the greatest propensity for harboring dysplasia and malignancy 2.
Serrated Lesions
The British Society of Gastroenterology established clear nomenclature for these increasingly recognized precursor lesions 3:
Hyperplastic polyps (HP): The most common serrated lesion, accounting for 83-96% of all serrated polyps and 24-42% of all colorectal polyps. These are typically found in the left colon and rectosigmoid. Diminutive HPs in the rectosigmoid are not considered risk markers for future colorectal cancer 3.
Sessile serrated lesions (SSL): Represent 2-4% of all polyps and 3-11% of serrated lesions. These occur more often in the proximal colon and have molecular features consistent with being precursors to 15-30% of all colorectal cancers 3. SSLs are characterized by subtle endoscopic appearance—predominantly flat with indistinct borders, clouded surface, irregular shape, and dark spots inside crypts 4.
SSL with dysplasia: A critical distinction representing SSLs on an accelerated pathway to carcinogenesis. These require more aggressive surveillance 3.
Traditional serrated adenomas (TSA): Much less common, accounting for <1% of all polyps and 1-7% of serrated lesions. These are usually found in the left colon 3.
Mixed polyps: Unusual cases showing features of both SSL and TSA, or representing true collision tumors 3.
Non-Neoplastic Polyps
Inflammatory polyps: Arise in the context of inflammatory bowel disease or other inflammatory conditions 5.
Inflammatory myoglandular polyps: Distinct entities characterized by inflammatory granulation tissue, smooth muscle proliferation, and hyperplastic glands. These appear as solitary pedunculated red polyps with smooth surfaces, typically in the sigmoid colon 6.
Hamartomatous polyps: Include juvenile polyps and Peutz-Jeghers polyps, which show tree-like proliferation of muscularis mucosae without inflammatory granulation tissue 6.
Critical Clinical Distinctions
Size matters but does not exclude risk: While advanced histopathology (TVA, high-grade dysplasia, or cancer) is more common in larger polyps (13.4% in polyps ≥10mm), one quarter of all advanced histopathology exists in polyps <10mm 1. Even polyps 1-5mm harbor advanced features in 0.6% of cases 1.
Location patterns differ by type: HPs and TSAs favor the left colon, while SSLs predominantly occur in the proximal colon 3. This anatomic distribution has implications for surveillance strategies.
Optical diagnosis is increasingly reliable: Using the NICE classification with narrow-band imaging, Type 1 lesions (same or lighter color than background, no vessels or isolated lacy vessels) represent hyperplastic and sessile serrated lesions, while Type 2 lesions (brown vessels with white structures) represent adenomas 4. The WASP criteria add four SSL-specific features to improve differentiation 4.
Common Pitfalls
The pathological distinction between HPs and SSLs becomes more challenging as lesion size decreases 3. WHO criteria require three crypts—or two adjacent crypts—showing characteristic features for SSL diagnosis 3. Incomplete removal of SSLs occurs at much higher rates than conventional adenomas (31% vs 7.2%), reaching 47.6% in large lesions, due to their subtle flat appearance and indistinct borders 4.